Kane Huang

Senior Associate

Tokyo

Kane Huang, a senior associate in Orrick's Tokyo office, is a member of the M&A and Private Equity Group.

Kane advises U.S., and Japanese companies on cross-border M&A, joint venture, strategic investments, technology licensing, and energy related transactions, as well as compliance, corporate governance, and general corporate matters.

In addition to transactions between U.S., and Japanese companies, Kane works on a variety of multijurisdictional transactions involving entities and assets in Asia and Europe.

Kane has gained client-side experience from his secondments to a U.S. and Japan joint venture appliances company from 2015 to 2016, a Japan subsidiary of a U.S. based elevator and escalator company in 2016, and a Japan electric utility company from 2019 to 2020.

Kane worked at Orrick’s Silicon Valley office from 2010 to 2012, where he focused on technology sector M&A.

    • Assisted a Japanese cryptocurrency exchange company on its sale to a crypto derivative exchange company.
    • Assisted a Japanese chemical company in its acquisition of 45% stakes in a leading Japanese manufacturer of specialty chemicals, from a U.S.-based global technology and specialty material company.
    • General assistance to a Japan venture capital investment firm in its investments into U.S. and U.K. based companies, including in biotechnology and computing.
    • Assisted a Japanese chemical company in its acquisitions of the plant health business from a leading animal health company.
    • Assisted Johnson Controls with its acquisition of a 60% interest in Hitachi Appliances’s global HVAC (heating, ventilating, and air conditioning) business and the creation of a global joint venture with Hitachi to develop, manufacture and sell HVAC systems.
    • Assisted U-Shin, a Japan based car parts manufacturer, in its acquisition of a global car access mechanisms business from French company Valeo.
    • Assisted a Japan based global chemical company in its acquisition of the Tebufenozide insecticide business of a wholly owned subsidiary of The Dow Chemical Company.